In an article published Online First in JAMA Neurology, researchers suggest that, while isolated psychiatric episodes are rare in anti-NMDAR encephalitis cases, abnormal test findings or
subtle neurological symptoms should prompt screening for the condition, as it is treatable with immunotherapies.